IGF-II mRNA binding protein 1 (IGF2BP1), which participates in the Wnt/β-catenin pathway, is a target of miR-372 in the RCC cell lines, thus miR-372 acts as a tumor suppressor (Huang et al., 2015). Here, IGF2BP1 is linked to renal cell carcinoma.